Abstract #0036
Hybrid PET/MRI for Evaluation of Nodal Disease in Lymphoma
Laura Heacock 1 , Joseph Weissbrot 1 , Roy Raad 1 , Naomi Campbell 1 , Kent Friedman 1 , Christian Geppert 2 , and Hersh Chandarana 1
1
Radiology, NYU Langone Medical
Center, New York, NY, United States,
2
Siemens
Medical Solutions, New York, NY, United States
PET/CT is routinely performed in evaluation of
disease burden in patients with Non Hodgkin
Lymphoma (NHL). MRI with diffusion weighted
imaging (DWI) has shown promise. In this study
we compared the accuracy of morphologic MRI
including DWI and PET/MR in detection of nodal
disease with PET/CT as a reference. Our results
suggest that PET/MR outperformed DWI for
assessment of nodal disease and had sensitivity
similar to PET/CT. Furthermore there was
excellent correlation in SUVmax as measured with
PET/MR and PET/CT. Thus PET/MR may be a viable
option to PET/CT in evaluation of patients with
lymphoma.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
